EUCTR2014-002227-96-SE进行中（未招募）不适用
Inhibition of platelet aggregation after administration of three different ticagrelor loading dose formulations in patients with stable angina referred for coronary angiography - IPAAD-Tica
County Council of Östergötland0 个研究点开始时间: 2014年7月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with stable angina referred for coronary angiography
- •Ability to provide informed consent
- •Age 18 years or older
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Pregnacy or lactation, chronic therapy with ticagrelor, prasugrel, clopidogrel or ticlopidine, treatment with warfarin or NOAC in the last 4 days, active bleeding or increased risk of bleeding, history of gastrointestinal or geniourinary bleeding in the last 2 months, history of intracranial bleeding, major surgery in the last 4 weeks, severe anaemia or thrombocytopenia, severe liver or renal disease, increased risk of bradycardia, unable to chew tablet.
研究者
相似试验
已完成
不适用
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrelIschemic heart diseases with PICJPRN-UMIN000014161Kazuo Umemura Center for clinical research Hamamatsu University Hospital50
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABGEUCTR2008-001135-35-CZThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-GBThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-NLThe Medicines Company220
已完成
2 期
Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trialplatelet inhibition10011082NL-OMON34815Medicines Company50